August 1, 2025

Onchocerciasis-associated skin and ocular disease and the impact of ivermectin treatment on morbidity prevalence: a modelling study

View Full Paper

Ask AI

Bookmark

Modeling reveals significant onchocerciasis morbidity associated with skin and eye diseases.
Ivermectin treatment impacts morbidity prevalence, showing potential trends in infection reduction.
Morbidity outcomes were integrated into a stochastic transmission model to assess disease burden.
Findings underscore the need for improved intervention strategies and better disease burden estimates.

Discussion

No takes yet. Share an insight, caveat, or question.

Modeling shows ivermectin treatment reduces onchocerciasis morbidity in sub-Saharan Africa, suggesting improved intervention strategies.

Dixon et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark